263 related articles for article (PubMed ID: 1311464)
1. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
2. Kidney trace metal response to combined cisplatin (CDDP) and hyperthermia.
Dewoskin RS; Page RL; Riviere JE
Int J Hyperthermia; 1993; 9(4):529-37. PubMed ID: 8366303
[TBL] [Abstract][Full Text] [Related]
3. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
4. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
Jones MM; Basinger MA
J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
6. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
7. Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study.
Saad SY; Najjar TA; Noreddin AM; Al-Rikabi AC
Pharmacol Res; 2001 Feb; 43(2):193-8. PubMed ID: 11243722
[TBL] [Abstract][Full Text] [Related]
8. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats.
Nematbakhsh M; Ashrafi F; Safari T; Talebi A; Nasri H; Mortazavi M; Khazaei M; Baradaran-Mahdavi MM
J Nephrol; 2012; 25(3):410-7. PubMed ID: 21928232
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
10. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
Jones MM; Basinger MA; Mitchell WM; Bradley CA
Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
[TBL] [Abstract][Full Text] [Related]
13. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
Hayashi T; Watanabe Y; Kumano K; Kitayama R; Muratani T; Yasuda T; Saikawa I; Katahira J; Kumada T; Shimizu K
Antimicrob Agents Chemother; 1989 Apr; 33(4):513-8. PubMed ID: 2729945
[TBL] [Abstract][Full Text] [Related]
15. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
Saad SY; Al-Rikabi AC
Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
[TBL] [Abstract][Full Text] [Related]
16. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
Kempf SR; Ivankovic S; Wiessler M; Schmähl D
Br J Cancer; 1985 Dec; 52(6):937-9. PubMed ID: 3935152
[No Abstract] [Full Text] [Related]
17. Modification of the bone marrow toxicity of cis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate.
Evans RG; Wheatley C; Engel C; Nielsen J; Ciborowski LJ
Cancer Res; 1984 Sep; 44(9):3686-90. PubMed ID: 6331656
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats.
Mansour MA; Mostafa AM; Nagi MN; Khattab MM; Al-Shabanah OA
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jun; 132(2):123-8. PubMed ID: 12106889
[TBL] [Abstract][Full Text] [Related]
19. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of elastase on cis-platinum-induced renal toxicity.
Suzuki M; Sekiguchi I; Tamada T; Tsuru S
Oncology; 1991; 48(6):474-9. PubMed ID: 1749585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]